Artemisinins: Pharmacological actions beyond anti-malarial

Pharmacology and Therapeutics

Volumn 142, Issue 1, 2014, Pages 126-139

  Ho, Wanxing Eugene ^a,b,c   Peh, Hong Yong ^a   Chan, Tze Khee ^a,c   Wong, W S Fred ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Allergy; Artesunate; Autoimmune disorder; Cancer; Dihydroartemisinin; Infection

Indexed keywords

ANTIINFECTIVE AGENT; ARTEETHER; ARTEMETHER; ARTEMISIDE; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTEMISONE; ARTESUNATE; DIHYDROARTEMISININ; MS 905; SM 934; UNCLASSIFIED DRUG;

ALLERGY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPARASITIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL PHARMACOLOGY; DRUG ACTIVITY; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; INFECTION; MALARIA; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

ALLERGY; ARTESUNATE; AUTOIMMUNE DISORDER; CANCER; DIHYDROARTEMISININ; INFECTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; ANTIPARASITIC AGENTS; ANTIVIRAL AGENTS; ARTEMISININS; HUMANS;

EID: 84896719929     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.12.001     Document Type: Review

References (190)

1. D.D.F.Á. Alcântara, H.F. Ribeiro, P.C.D.S. Cardoso, T.M.T. Araújo, R.R. Burbano, and A.C. Guimarães et al. In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100) J Appl Toxicol 33 2013 151 156
2. L. Anfosso, T. Efferth, A. Albini, and U. Pfeffer Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins Pharmacogenomics J 6 2006 269 278
3. R. Arav-Boger, R. He, C.J. Chiou, J. Liu, L. Woodard, and A. Rosenthal et al. Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers PLoS One 5 2010 e10370
4. K.T. Batty, T.M. Davis, L.T. Thu, T.Q. Binh, T.K. Anh, and K.F. Ilett Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria J Chromatogr B Biomed Appl 677 1996 345 350
5. A.C. Beekman, A.R. Barentsen, H.J. Woerdenbag, W. Van Uden, N. Pras, and A.W. Konings et al. Stereochemistry-dependent cytotoxicity of some artemisinin derivatives J Nat Prod 60 1997 325 330
6. R.L. Berens, E.C. Krug, P.B. Nash, and T.J. Curiel Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin J Infect Dis 177 1998 1128 1131
7. T.G. Berger, D. Dieckmann, T. Efferth, E.S. Schultz, J.-O. Funk, and A. Baur et al. Artesunate in the treatment of metastatic uveal melanoma - first experiences Oncol Reports 14 2005 1599 1604
8. Y. Birku, E. Mekonnen, A. Bjorkman, and D. Wolday Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin Ethiop Med J 40 Suppl. 1 2002 17 26
9. S. Borrmann, N. Szlezak, J.F. Faucher, P.B. Matsiegui, R. Neubauer, and R.K. Binder et al. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study J Infect Dis 184 2001 1363 1366
10. D. Bourboulia, and W.G. Stetler-Stevenson Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion Semin Cancer Biol 20 2010 161 168
11. K.D. Brizendine, J.W. Baddley, and P.G. Pappas Pulmonary cryptococcosis Semin Respir Crit Care Med 32 2011 727 734
12. D. Bunnag, C. Viravan, S. Looareesuwan, J. Karbwang, and T. Harinasuta Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report Southeast Asian J Trop Med Public Health 22 1991 380 385
13. E. Buommino, A. Baroni, N. Canozo, M. Petrazzuolo, R. Nicoletti, and A. Vozza et al. Artemisinin reduces human melanoma cell migration by down-regulating αVβ3 integrin and reducing metalloproteinase 2 production Invest New Drugs 27 2009 412 418
14. M. Canel, A. Serrels, M.C. Frame, and C.G. Brunton E-cadherin-integrin crosstalk in cancer invasion and metastasis J Cell Sci 126 2013 403 413
15. D.J.E.A. Chen Experimental studies on antischistosomal activity of qinghaosu Zhong Hui Yi Xue Zha Zhi 60 1980 422 425
16. T. Chen, M. Li, R. Zhang, and H. Wang Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy J Cell Mol Med 13 2009 1358 1370
17. H. Chen, and H.I. Maibach Topical application of artesunate on guinea pig allergic contact dermatitis Contact Dermatitis 30 1994 280 282
18. H. Chen, B. Sun, S. Pan, H. Jiang, and X. Sun Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo Anticancer Drugs 20 2009 131 140
19. H. Chen, B. Sun, S. Wang, S. Pan, Y. Gao, and X. Bai et al. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB J Cancer Res Clin Oncol 136 2010 897 903
20. H.H. Chen, H.J. Zhou, G.D. Wu, and X.E. Lou Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1 Pharmacology 71 2004 1 9
21. C. Cheng, W.E. Ho, F.Y. Goh, S.P. Guan, L.R. Kong, and W.Q. Lai et al. Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway PLoS One 6 2011 e20932
22. C. Cheng, D.S. Ng, T.K. Chan, S.P. Guan, W.E. Ho, and A.H. Koh et al. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models Allergy 68 2013 195 203
23. J.E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N.M. Droin, D.D. Newmeyer, and M. Schuler et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis Science 303 2004 1010 1014
24. A.S. Chung, and N. Ferrara Development and pathological angiogenesis Annu Rev Cell Dev 27 2011 563 584
25. X. Cui, Y. Wang, N. Kokudo, D. Fang, and W. Tang Traditional Chinese medicine and related active compounds against hepatitis B virus infection Biosci Trends 4 2010 39 47
26. S. Cuzzocrea, F. Saadat, R. Di Paola, and A. Mirshafiey Artemether: a new therapeutic strategy in experimental rheumatoid arthritis Immunopharmacol Immunotoxicol 27 2005 615 630
27. J.G. D'Angelo, C. Bordon, G.H. Posner, R. Yolken, and L. Jones-Brando Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle J Antimicrob Chemother 63 2009 146 150
28. T.R. Daniels, E. Bernabeu, J.A. Rodríguez, S. Patel, M. Kozman, and D.A. Chiappetta et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer Biochim Biophys Acta 1820 2012 291 317
29. D. De Clercq, J. Vercruysse, A. Kongs, P. Verle, J.P. Dompnier, and P.C. Faye Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren Acta Trop 82 2002 61 66
30. R. Dell'Eva, U. Pfeffer, R. Vené, L. Anfosso, A. Forlani, and A. Albini et al. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate Biochem Pharmacol 68 2004 2359 2366
31. X.C. Ding, H.P. Beck, and G. Raso Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets Trends Parasitol 27 2011 73 81
32. A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N. White Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial Lancet 366 2005 717 725
33. A.M. Dondorp, S. Yeung, L. White, C. Nguon, N.P.J. Day, and D. Socheat et al. Artemisinin resistance: current status and scenarios for containment Nat Rev Microbiol 8 2010 272 280
34. J.E. Donelson Antigenic variation and the African trypanosome genome Acta Trop 85 2003 391 404
35. J.-H. Du, H.-D. Zhang, Z.-J. Ma, and K.-M. Ji Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo Cancer Chemother Pharmacol 65 2010 895 902
36. S.K. Dube, P.S. Panda, G.R. Agrawal, and D.K. Singh Anaphylaxis to artesunate? Indian J Crit Care Med 16 2012 55 57
37. I.R. Dunay, W.C. Chan, R.K. Haynes, and L.D. Sibley Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model Antimicrob Agents Biother 53 2009 4450 4456
38. T. Efferth, A. Benakis, M.R. Romero, M. Tomicic, R. Rauh, and D. Steinbach et al. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron Free Radic Biol Med 37 2004 998 1009
39. T. Efferth, H. Dunstan, A. Sauerbrey, H. Miyachi, and C. Chitambar The anti-malarial artesunate is also active against cancer Int J Oncol 18 2001 767 773
40. T. Efferth, M. Giaisi, A. Merling, P.H. Krammer, and M. Li-Weber Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells PLoS One 2 2007 e693
41. T. Efferth, and B. Kaina Toxicity of the antimalarial artemisinin and its derivatives Crit Rev Toxicol 40 2010 405 421
42. T. Efferth, M. Marschall, X. Wang, S.M. Huong, I. Hauber, and A. Olbrich et al. Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses J Mol Med (Berl) 80 2002 233 242
43. T. Efferth, M.R. Romero, D.G. Wolf, T. Stamminger, J.J. Marin, and M. Marschall The antiviral activities of artemisinin and artesunate Clin Infect Dis 47 2008 804 811
44. T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch, and H.O. Weber et al. Molecular modes of action of artesunate in tumor cell lines Mol Pharmacol 64 2003 382 394
45. S. Ekthawatchai, S. Kamchonwongpaisan, P. Kongsaeree, B. Tarnchompoo, Y. Thebtaranonth, and Y. Yuthavong C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene J Med Chem 44 2001 4688 4695
46. E.A. El-Bassiouni, M.H. Helmy, E.I. Saad, M.A. El-Nabi Kamel, E. Abdel-Meguid, and H.S. Hussein Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether Br J Biomed Sci 64 2007 168 174
47. J.F. Ferreira, P. Peaden, and J. Keiser In vitro trematocidal effects of crude alcoholic extracts of Artemisia annua, A. absinthium, Asimina triloba, and Fumaria officinalis: trematocidal plant alcoholic extracts Parasitol Res 109 2011 1585 1592
48. M.V. Fiandalo, and N. Kyprianou Caspase control: protagonists of cancer cell apoptosis Exp Oncol 34 2012 165 175
49. G.L. Firestone, and S.N. Sundar Anticancer activities of artemisinin and its bioactive derivatives Exp Rev Mol Med 11 2009 (null-null)
50. A.M. Galal, S.A. Ross, M. Jacob, and M.A. ElSohly Antifungal activity of artemisinin derivatives J Nat Prod 68 2005 1274 1276
51. P. Gautam, S.K. Upadhyay, W. Hassan, T. Madan, R. Sirdeshmukh, and C.S. Sundaram et al. Transcriptomic and proteomic profile of Aspergillus fumigatus on exposure to artemisinin Mycopathologia 172 2011 331 346
52. Y. Gong, B.M. Gallis, D.R. Goodlett, Y. Yang, H. Lu, and E. Lacoste et al. Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines Anticancer Res 33 2013 123 132
53. J. Guo, A.W. Guiguemde, A. Bentura-Marciano, J. Clark, R.K. Haynes, and W.C. Chan et al. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria Antimicrob Agents Chemother 56 2012 163 173
54. A. Hamacher-Brady, H.A. Stein, S. Turschner, I. Toegel, R. Mora, and N. Jennewein et al. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production J Biol Chem 286 2011 6587 6601
55. D. Hanahan, and R.A. Weinberg The hallmarks of cancer: the next generation Cell 144 2011 646 674
56. G. Harter, and D. Michel Antiviral treatment of cytomegalovirus infection: an update Expert Opin Pharmacother 13 2012 623 627
57. Y. He, J. Fan, H. Lin, X. Yang, Y. Ye, and L. Liang et al. The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1α in human rheumatoid arthritis fibroblast-like synoviocyte Rheumatol Int 31 2011 53 60
58. R. He, B.T. Mott, A.S. Rosenthal, D.T. Genna, G.H. Posner, and R. Arav-Boger An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities PLoS One 6 2011 e24334
59. C.P. Hencken, L. Jones-Brando, C. Bordon, R. Stohler, B.T. Mott, and R. Yolken et al. Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii J Med Chem 53 2010 3594 3601
60. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
61. W.E. Ho, C. Cheng, H.Y. Peh, F. Xu, S.R. Tannenbaum, and C.N. Ong et al. Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma Free Radic Biol Med 53 2012 498 507
62. L.F. Hou, S.J. He, X. Li, C.P. Wan, Y. Yang, and X.H. Zhang et al. SM934 treated lupus-prone NZB x NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development PLoS One 7 2012 e32424
63. L.F. Hou, S.J. He, X. Li, Y. Yang, P.L. He, and Y. Zhou et al. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses Arthritis Rheum 63 2011 2445 2455
64. L.F. Hou, S.J. He, J.X. Wang, Y. Yang, F.H. Zhu, and Y. Zhou et al. SM934, a water-soluble derivative of artemisinin, exerts immunosuppressive functions in vitro and in vivo Int Immunopharmacol 9 2009 1509 1517
65. X.Y. Hou, D.P. McManus, D.J. Gray, J. Balen, X.S. Luo, and Y.K. He et al. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China Bull World Health Organ 86 2008 788 795
66. X.J. Huang, Z.Q. Ma, W.P. Zhang, Y.B. Lu, and E.Q. Wei Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells J Pharm Pharmacol 59 2007 849 856
67. P.C. Inyang-Etoh, G.C. Ejezie, M.F. Useh, and E.C. Inyang-Etoh Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria Trans R Soc Trop Med Hyg 103 2009 38 44
68. K. Ito, C. Herbert, J.S. Siegle, C. Vuppusetty, N. Hansbro, and P.S. Thomas et al. Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma Am J Respir Cell Mol Biol 39 2008 543 550
69. C.W. Jefford, M.G.H. Vicente, Y. Jacquier, F. Favarger, J. Mareda, P. MillassonSchmidt, G. Brunner, and U. Burger The deoxygenation and isomerization of artemisinin and artemether and their relevance to antimalarial action Helvetica Chimica Acta 79 1996 1475 1487
70. T. Jelinek Artemisinin based combination therapy in travel medicine Travel Med Infect Dis 11 2013 23 28
71. W. Jiang, B. Li, X. Zheng, X. Liu, Y. Cen, and J. Li et al. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin Int Immunopharmacol 11 2011 1065 1073
72. Y. Jiao, C.-M. Ge, Q.-H. Meng, J.-P. Cao, J. Tong, and S.-J. Fan Dihydroartemisinin is an inhibitor of ovarian cancer cell growth Acta Pharmacol Sin 28 2007 1045 1056
73. O. Jin, H. Zhang, Z. Gu, S. Zhao, T. Xu, and K. Zhou et al. A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL/lpr murine model of systemic lupus erythematosus Cell Mol Immunol 6 2009 461 467
74. L. Jones-Brando, J. D'Angelo, G.H. Posner, and R. Yolken In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin Antimicrob Agents Chemother 50 2006 4206 4208
75. S.J. Kaptein, T. Efferth, M. Leis, S. Rechter, S. Auerochs, and M. Kalmer et al. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo Antiviral Res 69 2006 60 69
76. O.Y. Ke, E.C. Krug, J.J. Marr, and R.L. Berens Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives Antimicrob Agents Chemother 34 1990 1961 1965
77. J. Keiser, and G. Morson Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether Exp Parasitol 118 2008 228 237
78. J. Keiser, L. Rinaldi, V. Veneziano, L. Mezzino, M. Tanner, and J. Utzinger et al. Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep Parasitol Res 103 2008 517 522
79. J. Keiser, and J. Utzinger Artemisinins and synthetic trioxolanes in the treatment of helminth infections Curr Opin Infect Dis 20 2007 605 612
80. J. Keiser, and J. Utzinger Food-borne trematodiases Clin Microbiol Rev 22 2009 466 483
81. J. Keiser, M. Vargas, and M.J. Doenhoff Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immunocompetent NMRI mice Am J Trop Med Hyg 82 2010 112 114
82. S.J. Kim, M.S. Kim, J.W. Lee, C.H. Lee, H. Yoo, and S.H. Shin et al. Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro J Cancer Res Clin Oncol 132 2006 129 135
83. P.G. Kremsner, and S. Krishna Antimalarial combinations Lancet 364 2004 285 294
84. S. Krishna, L. Bustamante, R.K. Haynes, and H.M. Staines Artemisinins: their growing importance in medicine Trends Pharmacol Sci 29 2008 520 527
85. S. Krishna, S. Pulcini, F. Fatih, and H. Staines Artemisinins and the biological basis for the PfATP6/SERCA hypothesis Trends Parasitol 26 2010 517 523
86. H. Lai, I. Nakase, E.P.S.N. Lacoste, and T. Sasaki Artemisinin- transferrin conjugate retards growth of breast tumors in the rat Anticancer Res 29 2009 3807 3810
87. E. Leonardi, G. Gilvary, N.J. White, and F. Nosten Severe allergic reactions to oral artesunate: a report of two cases Trans R Soc Trop Med Hyg 95 2001 182 183
88. Y. Li Qinghaosu (artemisinin): chemistry and pharmacology Acta Pharmacol Sin 33 2012 1141 1146
89. T. Li, H. Chen, X.G. Liu, Y.X. Zhou, and S.F. Bai Immunoregulatory effect of artesunate on allergic contact dermatitis and its mechanism Yao Xue Xue Bao 47 2012 884 889
90. T. Li, H. Chen, N. Wei, X. Mei, S. Zhang, and D.L. Liu et al. Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity Int Immunopharmacol 12 2012 144 150
91. W.D. Li, Y.J. Dong, Y.Y. Tu, and Z.B. Lin Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-α and blocking the signaling pathway NF-κB translocation Int Immunopharmacol 6 2006 1243 1250
92. B. Li, J. Li, X. Pan, G. Ding, H. Cao, and W. Jiang et al. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-α release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-κB activation Int Immunopharmacol 10 2010 344 350
93. H.J. Li, W. Wang, Y.Z. Li, G.L. Qu, Y.T. Xing, and Y.H. Tao et al. Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum Parasitol Res 109 2011 515 519
94. H.J. Li, W. Wang, G.L. Qu, Y.Z. Li, Y.H. Tao, and Y.T. Xing et al. Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice Parasitol Res 110 2012 1727 1732
95. Y. Li, S. Wang, Y. Wang, C. Zhou, G. Chen, and W. Shen et al. Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway Transl Res 161 2013 89 98
96. B. Li, R. Zhang, J. Li, L. Zhang, G. Ding, and P. Luo et al. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-κB activation Int Immunopharmacol 8 2008 379 389
97. L.N. Li, H.D. Zhang, S.J. Yuan, D.X. Yang, L. Wang, and Z.X. Sun Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of β-catenin and E-cadherin Eur J Pharmacol 588 2008 1 8
98. R.J. Liang, and R. Albrecht Safety evaluations of drugs containing artemisinin derivatives for the treatment of malaria Clin Infect Dis 36 2003 1626 1627
99. R. Liu, H.F. Dong, Y. Guo, Q.P. Zhao, and M.S. Jiang Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis Parasit Vectors 4 2011 201
100. M.C. Lombard, D.D. N'Da, J.C. Breytenbach, N.I. Kolesnikova, C. Tran Van Ba, and S. Wein et al. Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in mice Eur J Pharm Sci 47 2012 834 841
101. Y.-Y. Lu, T.-S. Chen, J.-L. Qu, W.-L. Pan, L. Sun, and X.-B. Wei Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells J Biomed Sci 16 2009 16
102. J.-J. Lu, S.-M. Chen, X.-W. Zhang, J. Ding, and L.-H. Meng The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells Invest New Drugs 29 2011 1276 1283
103. J.J. Lu, L.H. Meng, Y.J. Cai, Q. Chen, L.J. Tong, and L.P. Lin et al. Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species Cancer Biol Ther 7 2008 1017 1023
104. K. Maneechotesuwan, S. Essilfie-Quaye, S.A. Kharitonov, I.M. Adcock, and P.J. Barnes Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils Chest 132 2007 98 105
105. S.R. McDougall, A.R.A. Anderson, and M.A.J. Chaplain Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies J Theor Biol 241 2006 564 589
106. R. McGready, S.J. Lee, J. Wiladphaingern, E.A. Ashley, M.J. Rijken, and M. Boel et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study Lancet Infect Dis 12 2012 388 396
107. V. Melendez, J.O. Peggins, T.G. Brewer, and A.D. Theoharides Determination of the antimalarial arteether and its deethylated metabolite dihydroartemisinin in plasma by high-performance liquid chromatography with reductive electrochemical detection J Pharm Sci 80 1991 132 138
108. S.R. Meshnick, A. Thomas, A. Ranz, C.M. Xu, and H.Z. Pan Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action Mol Biochem Parasitol 49 1991 181 189
109. M. Michaelis, M.C. Kleinschmidt, S. Barth, F. Rothweiler, J. Geiler, and R. Breitling et al. Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines Biochem Pharmacol 79 2010 130 136
110. J. Milbradt, S. Auerochs, K. Korn, and M. Marschall Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate J Clin Virol 46 2009 24 28
111. A. Mirshafiey, F. Saadat, M. Attar, R. Di Paola, R. Sedaghat, and S. Cuzzocrea Design of a new line in treatment of experimental rheumatoid arthritis by artesunate Immunopharmacol Immunotoxicol 28 2006 397 410
112. Y.V. Mishina, S. Krishna, R.K. Haynes, and J.C. Meade Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth Antimicrob Agents Chemother 51 2007 1852 1854
113. H.Y. Mo, L.F. Wang, and L.H. Zhang Effects of artesunate on tumor necrosis factor alpha and chemotactic factors in the serum and the synoviocyte culture supemate of collagen-induced arthritis rats Zhongguo Zhong Xi Yi Jie He Za Zhi 32 2012 253 256
114. M.K. Mohapatra, D. Srinivas, A.K. Kar, and M. Murmu Anaphylactic reaction to intravenous artesunate J Assoc Physicians India 57 2009 183 184
115. B.T. Mott, A. Tripathi, M.A. Siegler, C.D. Moore, D.J. Sullivan, and G.H. Posner Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs J Med Chem 56 2013 2630 2641
116. D. Mu, W. Zhang, D. Chu, T. Liu, Y. Xie, and E. Fu et al. The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells Cancer Chemother Pharmacol 61 2008 639 645
117. K. Nagamune, S.N. Moreno, and L.D. Sibley Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis Antimicrob Agents Chemother 51 2007 3816 3823
118. I. Nakase, B. Gallis, T. Takatani-Nakase, S. Oh, E. Lacoste, and N.P. Singh et al. Transferrin receptor-dependent cytotoxicity of artemisinin- transferrin conjugates on prostate cancer cells and induction of apoptosis Cancer Lett 274 2009 290 298
119. I. Nakase, H. Lai, N.P. Singh, and T. Sasaki Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation Int J Pharm 354 2008 28 33
120. P. Newton, Y. Suputtamongkol, P. Teja-Isavadharm, S. Pukrittayakamee, V. Navaratnam, and I. Bates et al. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria Antimicrob Agents Chemother 44 2000 972 977
121. D.X. Nguyen, and J. Massague Genetic determinants of cancer metastasis Nat Rev Genet 8 2007 341 352
122. E. Nibret, and M. Wink Volatile components of four Ethiopian Artemisia species extracts and their in vitro antitrypanosomal and cytotoxic activities Phytomedicine 17 2010 369 374
123. N.M. Njuguna, D.S.B. Ongarora, and K. Chibale Artemisinin derivatives: a patent review (2006-present) Expert Opin Ther Patents 22 2012 1179 1203
124. P.M. O'Neill, V.E. Barton, and S.A. Ward The molecular mechanism of action of artemisinin-the debate continues Molecules 15 2010 1705 1721
125. J.F. O'Neill, R.C. Johnston, L. Halferty, G.P. Brennan, J. Keiser, and I. Fairweather Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model J Helminthol 83 2009 151 163
126. J. Paeshuyse, L. Coelmont, I. Vliegen, l, J. Van heme, J. Vandenkerckhove, and E. Peys et al. Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin Biochem Biophys Res Commun 348 2006 139 144
127. I.-H. Paik, S. Xie, T.A. Shapiro, T. Labonte, A.A. Narducci Sarjeant, and A.C. Baege et al. Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity J Med Chem 49 2006 2731 2734
128. G.H. Posner, D.J. McGarvey, C.H. Oh, N. Kumar, S.R. Meshnick, and W. Asawamahasadka Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin J Med Chem 38 1995 607 612
129. Prevention and control of schistosomiasis and soil-transmitted helminthiasis World Health Organization Technical Report Series 912 2002 1 57 (i-vi, back cover)
130. M. Ramacher, V. Umansky, and T. Efferth Effect of artesunate on immune cells in ret-transgenic mouse melanoma model Anticancer Drugs 20 2009 910 917
131. S.A.K. Rasheed, T. Efferth, I.A. Asangani, and H. Allgayer First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases Int J Cancer 127 2010 1475 1485
132. N. Rhind, and P. Russell Signaling pathways that regulate cell division Cold Spring Harb Perspect Biol 4 2012 a005942
133. C. Riganti, S. Doublier, D. Viarisio, E. Miraglia, G. Pescarmona, and D. Ghigo et al. Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression Br J Pharmacol 156 2009 1054 1066
134. J. Rius, M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, and V. Nizet et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α Nature 453 2008 807 811
135. M.R. Romero, T. Efferth, M.A. Serrano, B. Castano, R.I. Macias, and O. Briz et al. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system Antiviral Res 68 2005 75 83
136. A. Schreiber, G. Harter, A. Schubert, D. Bunjes, T. Mertens, and D. Michel Antiviral treatment of cytomegalovirus infection and resistant strains Exp Opin Pharmacother 10 2009 191 209
137. S.H. Seif el-Din, A.M. Al-Hroob, and F.A. Ebeid Schistosoma mansoni: N-acetylcysteine downregulates oxidative stress and enhances the antischistosomal activity of artemether in mice Exp Parasitol 128 2011 230 235
138. S. Sertel, P. Plinkert, and T. Efferth Activity of artemisinin-type compounds against cancer cells H. Wagner, G. Ulrich-Merzenich, Evidence and Rational Based Research on Chinese Drugs 2013 Springer Vienna 333 362
139. L. Shakir, M. Hussain, A. Javeed, M. Ashraf, and A. Riaz Artemisinins and immune system Eur J Pharmacol 668 2011 6 14
140. M.Y. Shapira, I.B. Resnick, S. Chou, A.U. Neumann, N.S. Lurain, and T. Stamminger et al. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation Clin Infect Dis 46 2008 1455 1457
141. M. Shen, H.L. Ge, Y.X. He, Q.L. Song, and H.Z. Zhang Immunosuppressive action of Qinghaosu Sci Sin B 27 1984 398 406
142. J.Q. Shi, C.C. Zhang, X.L. Sun, X.X. Cheng, J.B. Wang, and Y.D. Zhang et al. Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-κB and NLRP3 inflammasome activation CNS Neurosci Ther 19 2013 262 268
143. X. Shuhua, J. Chollet, N.A. Weiss, R.N. Bergquist, and M. Tanner Preventive effect of artemether in experimental animals infected with Schistosoma mansoni Parasitol Int 49 2000 19 24
144. X. Shuhua, P.J. Hotez, and M. Tanner Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome Southeast Asian J Trop Med Public Health 31 2000 724 732
145. X. Shuhua, Y. Jiqing, M. Jinying, G. Huifang, J. Peiying, and M. Tanner Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits Parasitol Int 49 2000 25 30
146. C. Singh, R. Kanchan, S. Chaudhary, and S.K. Puri Linker-based hemisuccinate derivatives of artemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice J Med Chem 55 2012 1117 1126
147. N.P. Singh, and H. Lai Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells Life Sci 70 2001 49 56
148. N.P. Singh, H.C. Lai, J.S. Park, T.E. Gerhardt, B.J. Kim, and S. Wang et al. Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo Anticancer Res 31 2011 4111 4114
149. N.P. Singh, and V.K. Panwar Case report of a pituitary macroadenoma treated with artemether Integr Cancer Ther 5 2006 391 394
150. N.P. Singh, and K.B. Verma Case report of a laryngeal squamous cell carcinoma treated with artesunate Arch Oncol 10 2002 279 280
151. M.S. Sissoko, A. Dabo, H. Traore, M. Diallo, B. Traore, and D. Konate et al. Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children PLoS One 4 2009 e6732
152. L. Steinbruck, G. Pereira, and T. Efferth Effects of artesunate on cytokinesis and G2/M cell cycle progression of tumour cells and budding yeast Cancer Genomics Proteomics 7 2010 337 346
153. L.H. Stockwin, B. Han, S.X. Yu, M.G. Hollingshead, M.A. ElSohly, and W. Gul et al. Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction Int J Cancer 125 2009 1266 1275
154. X. Sun, S. Xie, Z. Long, Z. Zhang, and Y. Tu Experimental study on the immunosuppressive effects of qinghaosu and its derivative Zhongguo Zhong Xi Yi Jie He Za Zhi 11 1991 37 38
155. S.N. Sundar, C.N. Marconett, V.B. Doan, J.A. Willoughby Sr., and G.L. Firestone Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells Carcinogenesis 29 2008 2252 2258
156. A.F. Tawfik, S.J. Bishop, A. Ayalp, and F.S. el-Feraly Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice Int J Immunopharmacol 12 1990 385 389
157. S. Thomas, B.A. Quinn, S.K. Das, R. Dash, L. Emdad, and S. Dasgupta et al. Targeting the Bcl-2 family for cancer therapy Exp Opin Ther Targets 17 2013 61 75
158. A.S. Tin, S.N. Sundar, K.Q. Tran, A.H. Park, K.M. Poindexter, and G.L. Firestone Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes Anticancer Drugs 23 2012 370 379
159. J. Utzinger, J. Chollet, J. You, J. Mei, M. Tanner, and S. Xiao Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals Acta Trop 80 2001 9 18
160. J. Utzinger, S.H. Xiao, M. Tanner, and J. Keiser Artemisinins for
161. M.A. van Agtmael, T.A. Eggelte, and C.J. van Boxtel Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication Trends Pharmacol Sci 20 1999 199 205
162. J. Wang, B. Zhang, Y. Guo, G. Li, Q. Xie, B. Zhu, J. Gao, and Z. Chen Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C Pharmacology 82 2008 148 155
163. X. Wang, K. Fang, X.Q. Wang, H.J. Wang, X.B. Jia, and L.Y. Yang Inhibition effect and mechanism of artemisinin on surgically induced endometriosis Sichuan Da Xue Xue Bao Yi Xue Ban 42 2011 364 368
164. X.Q. Wang, H.L. Liu, G.B. Wang, P.F. Wu, T. Yan, and J. Xie et al. Effect of artesunate on endotoxin-induced uveitis in rats Invest Ophthalmol Vis Sci 52 2011 916 919
165. Y.Y. Wang, Y.X. Liu, Q.B. Xie, and G. Liu Effects of dihydroartemisinin on collagen II-induced arthritis in rats model Sichuan Da Xue Xue Bao Yi Xue Ban 43 2012 851 854
166. S.J. Wang, B. Sun, Z.X. Cheng, H.X. Zhou, Y. Gao, and R. Kong et al. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway Cancer Chemother Pharmacol 68 2011 1421 1430
167. J.X. Wang, W. Tang, R. Zhou, J. Wan, L.P. Shi, and Y. Zhang et al. The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses Br J Pharmacol 153 2008 1303 1310
168. J. Wang, B. Zhang, Y. Guo, G. Li, Q. Xie, and B. Zhu et al. Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C Pharmacology 82 2008 148 155
169. J. Wang, H. Zhou, J. Zheng, J. Cheng, W. Liu, and G. Ding et al. The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release Antimicrob Agents Chemother 50 2006 2420 2427
170. M. Wartenberg, S. Wolf, P. Budde, F. Grunheck, H. Acker, and J. Hescheler et al. The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies Lab Invest 83 2003 1647 1655
171. T. Weifeng, S. Feng, L. Xiangji, S. Changqing, Q. Zhiquan, and Z. Huazhong et al. Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells Phytomedicine 18 2011 158 162
172. S.M. Weis, and D.A. Cheresh Tumor angiogenesis: molecular pathways and therapeutic targets Nat Med 17 2011 1359 1370
173. J.A. Willoughby, S.N. Sundar, M. Cheung, A.S. Tin, J. Modiano, and G.L. Firestone Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression J Bio Chem 284 2009 2203 2213
174. Z.P. Wu, C.W. Gao, Y.G. Wu, Q.S. Zhu, C. Yan, and L. Xin et al. Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model Integr Cancer Ther 8 2009 88 92
175. B. Wu, K. Hu, S. Li, J. Zhu, L. Gu, and H. Shen et al. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer Oncol Reports 27 2012 101 108
176. J. Wu, D. Hu, G. Yang, J. Zhou, C. Yang, and Y. Gao et al. Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells J Cell Biochem 112 2011 1938 1948
177. X.L. Wu, W.S. Sun, X.M. Shi, Z. Wang, P. An, and C.L. Qiao Effect of artemisinin on the expressions of GRα mRNA, GRβ mRNA and P300/CBP protein in lupus nephritis mice Zhong Yao Cai 35 2012 608 612
178. X. Wu, W. Zhang, X. Shi, P. An, W. Sun, and Z. Wang Therapeutic effect of artemisinin on lupus nephritis mice and its mechanisms Acta Biochim Biophys Sin 42 2010 916 923
179. S.H. Xiao Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins Acta Trop 96 2005 153 167
180. S.H. Xiao, J.Q. You, J.Y. Mei, H.F. Guo, P.Y. Jiao, and H.L. Sun et al. Effect of artemether on glucose uptake and glycogen content in Schistosoma japonicum Acta Pharmacol Sin 18 1997 363 367
181. S.H. Xiao, J.Q. You, Y.Q. Yang, and C.Z. Wang Experimental studies on early treatment of schistosomal infection with artemether Southeast Asian J Trop Med Public Health 26 1995 306 318
182. W.L. Xie, P.H. Yang, X. Zeng, and J.Y. Cai Effect of 4-(12- dihydroartemisininoxy) benzoic acid hydrazide transferrin tagged drug on human breast cancer cells Chin J Anal Chem 37 2009 671 675
183. H. Xu, Y. He, X. Yang, L. Liang, Z. Zhan, and Y. Ye et al. Anti-malarial agent artesunate inhibits TNF-α-induced production of proinflammatory cytokines via inhibition of NF-κB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes Rheumatology (Oxford) 46 2007 920 926
184. Z. Yang, J. Ding, C. Yang, Y. Gao, X. Li, and X. Chen et al. Immunomodulatory and anti-inflammatory properties of artesunate in experimental colitis Curr Med Chem 19 2012 4541 4551
185. Y. Yang, S. Xiao, M. Tanner, J. Utzinger, J. Chollet, and J. Wu et al. Histopathological changes in juvenile Schistosoma haematobium harboured in hamsters treated with artemether Acta Trop 79 2001 135 141
186. M.K. Yoon, D.M. Mitrea, L. Ou, and R.W. Kriwacki Cell cycle regulation by the intrinsically disordered proteins p21 and p27 Biochem Soc Trans 40 2012 981 988
187. Q. Yu, and H. Jin Artesunate in treatment of dermatosis Acta Acad Med Bengbu 05 1997
188. Z.L. Zhai, P.Y. Jiao, J.Y. Mei, and S.H. Xiao Glutathione inhibits the antischistosomal activity of artemether Chin J Parasitol Parasit Dis 20 2002 212 215
189. Z. Zhang, S. Yu, L. Miao, X. Huang, X. Zhang, and Y. Zhu et al. Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial J Chin Integr Med 6 2008 134
190. D.Y. Zhu, B.S. Huang, Z.L. Chen, M.L. Yin, Y.M. Yang, and M.L. Dai et al. Isolation and identification of the metabolite of artemisinin in human Zhongguo Yao Li Xue Bao 4 1983 194 197